Sunday, March 10, 2024 10:59:37 PM
As to how it helps the stock price, well that's obvious and that's why it's a moot point for me. So the whys and whens are immaterial imo.
It should help the stock price because it means Sintx has a pathway to commercialize its ortho products with a major player. Sadly this information has never helped the stockprice. Sintx marketcap should be in the hundreds of millions not single millions.
For me, i want them to get moving already! Seriously, the longer they take to announce some sort of collaboration the longer it'll take for the products to get to market the more patients, like my wife, that get stuck with a metal implant. Could there have been a dental product on the market by now had they announced a collab back in 2017? No idea honestly because very little is revealed on the dental front but it seems a clinical trial could have been done years ago. Yes you have grounds to complain about little info about this.
How is he crapping on me? Because the stockprice sucks? Does Sonny control the price? He announces revenue has doubled the stock drops. He announces two aerospace revenue contracts and the stock drops. No matter the positive news, the price goes lower. I swear the better position Sintx is in the more the price seems to drop.
News is not fluff. Since when are developments on potential products fluff? Thats real legit news. Its just downplayed to help provide the narrative for the continued dropping of the stockprice as funds continue to short/naked short. How are patents a bad thing? How is diversifying revenue sources a bad thing? How is creating more product candidates a bad thing? One day, if Zimmer so chooses, it can sell all those Sintx products in ortho/antipathogenic portfolio. It could definitely diversify its revenue streams licensing products/oem supplier/printing blanks, etc.. if it acquired Sintx oneday. All depends on its roadmap.
Nothing about these Press releases represents fluff and instead represents another potential product for its portfolio or update on development.
This news represents a co-developed product to add to the portfolio:
January 30, 2024
SINTX SUBSIDIARY TECHNOLOGY ASSESSMENT & TRANSFER TO DEVELOP 3D PRINTING AND CMCs WITH DEVCOM-ARMY RESEARCH LABORATORY
This PR is federal grant money to aid in the development of yet another product and means less money needed from the companies coffers. This product could bring in Invibio like revenue one day.
October 11, 2023
SINTX Technologies Awarded Phase II NIH Grant for Silicon Nitride-PEEK 3D Printed Composite Spinal Implants
This news is means that, if successful, Sintx can 3D print Si3N4 implants. Not only does this lower manufacturing costs (how is that bad or fluff?) but also means they can address the one drawback of Si3N4 implants, its modulus of elasticity. 3d printing would allow them to reduce that so Si3n4 could be a standalone material for things like femoral stems.
August 17, 2023
3DCERAM SINTO INC. and SINTX TECHNOLOGIES ANNOUNCE COLLABORATION TO DEVELOP MATERIALS AND TECHNOLOGIES FOR ADDITIVE MANUFACTURING OF ADVANCED CERAMICS
This one was a pleasant update but meant little for the time being in regards to revenue. That said, this is standard procedure for companies to issue a press release on. Maybe Sintx has to go through a lengthy qualification process the way it did with Aerospace? IDK. You definitely have grounds for complaining about the lack of information on this.
I except revenue for this division from NP Aerospace in the future.
Feb 14, 2023
SINTX Technologies Announces Its New Utah Armor Facility Is Fully Operational
On and on it goes. Development news, offerings, development news, offerings, development, news reverse splits, etc... If Sintx was properly valued there would be far fewer offerings, far fewer shares per offering, and no reverse splits. Sadly Sintx is not properly valued and we get all those things in between development news.
========================================
Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
https://www.mdpi.com/2571-6131/4/2/16/htm
========================================
Electromagnetic fields, metal implant corrosion, and dis-ease it causes
https://i.imgur.com/nLg7SXT.jpg
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172932779
Could it be that there is a strategy to distract people away from looking at the basic data?
Is all this an exercise to create more and more forum verbiage to drown out any serious discussion of evidence?
Recent SINT News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 01:02:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/10/2026 01:00:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/19/2026 02:00:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/18/2026 01:35:38 PM
- SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial Platforms • GlobeNewswire Inc. • 02/18/2026 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/11/2026 01:45:54 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/11/2026 01:44:43 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/11/2026 01:43:48 AM
- SINTX Technologies to Participate in Noble Capital Markets’ Emerging Growth Virtual Equity Conference on February 4–5 • GlobeNewswire Inc. • 01/29/2026 02:00:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/12/2025 05:15:20 AM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 12/09/2025 10:01:07 PM
- Sidoti Events, LLC's Year-End Virtual Investor Conference • ACCESS Newswire • 12/09/2025 05:48:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/09/2025 01:00:05 PM
- SINTX Technologies to Participate in Sidoti & Company Investor Conference • GlobeNewswire Inc. • 12/08/2025 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/08/2025 01:00:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/01/2025 01:35:26 PM
- SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants • GlobeNewswire Inc. • 12/01/2025 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2025 01:05:43 PM
- SINTX Reports Pivotal Third Quarter Business Update and Financial Highlights Driven by FDA Clearance, Product and IP Portfolio Expansions and Increased Operational Efficiencies • GlobeNewswire Inc. • 11/13/2025 01:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 09:17:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/10/2025 01:00:06 PM
- SINTX Technologies Announces Launch of OsseoSculpt™ an Advanced Biologic for Use with SINAPTIC® Foot & Ankle Osteotomy Wedge System • GlobeNewswire Inc. • 11/03/2025 01:00:00 PM
Advances in Domestic Heavy Rare Earth Minerals Production Essential for North American Defense Stockpiles • ALOY • Mar 18, 2026 9:00 AM
ECGI Advances $10M Mortgage Tokenization Pilot as SEC Interpretation Adds Clarity • ECGI • Mar 18, 2026 8:45 AM
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
Cannabix Technologies Announces Commercial Launch of Marijuana Breath Test (MBT) • BLOZF • Mar 16, 2026 8:37 AM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
